SCHEMBL5817880

SCHEMBL5817880

CC(C)(C)OC(=O)N1CCN(c2nc(-c3cccc(F)c3)c(-c3ccnc(NC4CCCC4)n3)s2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 4/20 0.46
DYRK2 Q92630 1/20 0.43
RIPK2 O43353 1/20 0.41
CCNA2 P20248 2/20 0.41
CDK2 P24941 2/20 0.41
CDK1 P06493 1/20 0.41
CDK4 P11802 1/20 0.41
CCNB1 P14635 1/20 0.41
CCND1 P24385 1/20 0.41
CCND3 P30281 1/20 0.41
CDK7 P50613 1/20 0.41
CCNH P51946 1/20 0.41
CDK6 Q00534 1/20 0.41
DGAT1 O75907 2/20 0.41
CCNT1 O60563 2/20 0.41
CDK9 P50750 1/20 0.40
CCNA1 P78396 1/20 0.40
SYK P43405 1/20 0.39
MAPK8 P45983 1/20 0.39
ALOX5 P09917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5818376 0.99 BRAF (0.46) BRAFDYRK2RIPK2CCNA2CDK2
SCHEMBL5812799 0.97 BRAF (0.49) BRAFDYRK2RIPK2CCNA2CDK2
SCHEMBL5817960 0.92 MAPK14 (0.44) BRAFDYRK2RIPK2CCNA2CDK2
SCHEMBL5819222 0.91 SYK (0.45) BRAFDYRK2RIPK2CCNA2CDK2
SCHEMBL5815348 0.91 DGAT1 (0.44) BRAFDYRK2RIPK2CCNA2CDK2
SCHEMBL5818666 0.91 MAPK14 (0.43) BRAFDYRK2RIPK2CCNA2CDK2
SCHEMBL5817854 0.91 KCNH2 (0.48) DYRK2CCNA2CDK2CDK1CDK4
SCHEMBL5817754 0.91 SYK (0.44) BRAFDYRK2RIPK2CCNA2CDK2
SCHEMBL5818760 0.91 DGAT1 (0.45) BRAFDYRK2RIPK2CCNA2CDK2
SCHEMBL5812813 0.90 KCNH2 (0.47) DYRK2CCNA2CDK2CDK1CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed